These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19857955)

  • 1. Overcoming self-destruction in the pancreas.
    Nichols J; Cooke A
    Curr Opin Biotechnol; 2009 Oct; 20(5):511-5. PubMed ID: 19857955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different islet protein expression profiles during spontaneous diabetes development vs. allograft rejection in BB-DP rats.
    Christensen UB; Larsen PM; Fey S; Karlsen AE; Pociot F; Nerup J; Sparre T
    Autoimmunity; 2006 Jun; 39(4):315-21. PubMed ID: 16891220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Xenotransplantation of islets of Langerhans: a possible therapy for diabetes mellitus?].
    Igaz P
    Wien Med Wochenschr; 2001; 151(13-14):291-4. PubMed ID: 11582992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice.
    Casares S; Lin M; Zhang N; Teijaro JR; Stoica C; McEvoy R; Farber DL; Bona C; Brumeanu TD
    Transplantation; 2008 Jun; 85(12):1717-25. PubMed ID: 18580462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of type 1 diabetics by transplantation of isolated pancreatic islets].
    Ono J
    Rinsho Byori; 2006 Apr; 54(4):379-85. PubMed ID: 16722457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Islet replacement vs. regeneration: hope or hype?
    Ramiya V; Schatz D
    Pediatr Diabetes; 2004; 5 Suppl 2():45-56. PubMed ID: 15601374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreas transplantation: is islet transplantation the future?
    Fernandez-Cruz L; Casanovas D; Lloveras G
    Transplant Proc; 1992 Dec; 24(6):2379-82. PubMed ID: 1465802
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving islet transplantation: a road map for a widespread application for the cure of persons with type I diabetes.
    Korsgren O; Nilsson B
    Curr Opin Organ Transplant; 2009 Dec; 14(6):683-7. PubMed ID: 19779341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches to the prevention of immune destruction of transplanted pancreatic islets.
    Lafferty KJ; Hao L
    Transplant Proc; 1994 Apr; 26(2):399-400. PubMed ID: 8171476
    [No Abstract]   [Full Text] [Related]  

  • 10. Stem cell-based approaches to solving the problem of tissue supply for islet transplantation in type 1 diabetes.
    Street CN; Sipione S; Helms L; Binette T; Rajotte RV; Bleackley RC; Korbutt GS
    Int J Biochem Cell Biol; 2004 Apr; 36(4):667-83. PubMed ID: 15010331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ICOS pathway in autoimmune and alloimmune responses in NOD mice.
    Ansari MJ; Fiorina P; Dada S; Guleria I; Ueno T; Yuan X; Trikudanathan S; Smith RN; Freeman G; Sayegh MH
    Clin Immunol; 2008 Feb; 126(2):140-7. PubMed ID: 17889619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective and challenges of islet transplantation for the therapy of autoimmune diabetes.
    Balamurugan AN; Bottino R; Giannoukakis N; Smetanka C
    Pancreas; 2006 Apr; 32(3):231-43. PubMed ID: 16628077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
    Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of beta-cell function during immune-mediated, B7-1-dependent alpha-cell destruction.
    Skak K; Haase C; Michelsen BK
    Eur J Immunol; 2005 Sep; 35(9):2583-90. PubMed ID: 16078275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?
    Li DS; Warnock GL; Tu HJ; Ao Z; He Z; Lu H; Dai LJ
    Life Sci; 2009 Oct; 85(15-16):549-56. PubMed ID: 19747492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerogenic strategies to halt or prevent type 1 diabetes.
    Cooke A; Phillips JM; Parish NM
    Nat Immunol; 2001 Sep; 2(9):810-5. PubMed ID: 11526391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Islet transplantation: a realistic alternative for the treatment of insulin deficient diabetes mellitus.
    Kim KW
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S11-7. PubMed ID: 15563959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current indications and limits of pancreatic islet transplantation in diabetic nephropathy.
    Masetti M; Inverardi L; Ranuncoli A; Iaria G; Lupo F; Vizzardelli C; Kenyon NS; Alejandro R; Ricordi C
    J Nephrol; 1997; 10(5):245-52. PubMed ID: 9364315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of stem cells in diabetes.
    Roche E; Enseñat-Waser R; Reig JA; Jones J; León-Quinto T; Soria B
    Handb Exp Pharmacol; 2006; (174):147-67. PubMed ID: 16370328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological and biomaterial approaches for improved islet transplantation.
    Narang AS; Mahato RI
    Pharmacol Rev; 2006 Jun; 58(2):194-243. PubMed ID: 16714486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.